The United States healthcare landscape is facing intense scrutiny as DOJ crackdown Ivermectin U.S. health targets pharmaceutical companies, prescription practices, and compliance regulations. Amid this sweeping enforcement, Ivermectin—a drug once at the center of pandemic controversies—has re-emerged as a symbol of access, affordability, and patient...